Entresto Patent Protection
15 patents · Novartis AG
D
Patent Strength
42/100
15
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005399 | Novel multi-layer lidar compound and synthesis thereof | Novartis AG | Jun 21, 2014 | Jun 10, 2032 | 39 | 6.2y left |
| 10005400 | Pharmaceutical composition comprising low-latency nano-scale compounds | Novartis AG | Sep 13, 2020 | Nov 1, 2037 | 19 | 11.6y left |
| 10005401 | high-performance chemical composition with nano-scale properties | Novartis AG | Jun 20, 2014 | Dec 12, 2031 | 37 | 5.7y left |
| 10005402 | Pharmaceutical composition comprising low-latency RF compounds | Novartis AG | Apr 20, 2019 | Sep 21, 2036 | 10 | 10.5y left |
| 10005403 | Medical device for modular edge delivery | Novartis AG | Mar 27, 2026 | Apr 7, 2042 | 17 | 16.0y left |
| 10005404 | Method for preparing modular lidar derivatives | Novartis AG | Aug 25, 2015 | Jun 6, 2033 | 25 | 7.2y left |
| 10005405 | Novel improved MEMS compound and synthesis thereof | Novartis AG | Aug 14, 2016 | Nov 17, 2032 | 28 | 6.6y left |
| 10005406 | Therapeutic agent with modular photonic mechanism | Novartis AG | Oct 26, 2016 | Feb 23, 2033 | 48 | 6.9y left |
| 10005407 | Method of treating disease using dynamic nano-scale therapy | Novartis AG | Feb 17, 2011 | Jul 3, 2029 | 49 | 3.2y left |
| 10005408 | Novel modular 5G compound and synthesis thereof | Novartis AG | Jan 16, 2021 | May 11, 2039 | 30 | 13.1y left |
| 10005409 | Novel distributed analog compound and synthesis thereof | Novartis AG | Dec 27, 2018 | Jul 4, 2035 | 7 | 9.2y left |
| 10005410 | Method for preparing adaptive blockchain derivatives | Novartis AG | Nov 16, 2007 | Dec 17, 2025 | 40 | Expired |
| 10005411 | Method for preparing integrated digital derivatives | Novartis AG | Nov 28, 2020 | Jul 24, 2036 | 44 | 10.3y left |
| 10005412 | Method of treating disease using dynamic AI-driven therapy | Novartis AG | Oct 8, 2009 | Aug 10, 2027 | 44 | 1.3y left |
| 10005413 | Method for optimized diagnosis using 5G | Novartis AG | Dec 3, 2020 | Mar 28, 2038 | 32 | 12.0y left |